Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development

Fasciola hepatica is distributed worldwide, causing substantial economic losses in the animal husbandry industry. Human fasciolosis is an emerging zoonosis in Andean America, Asia, and Africa. The control of the disease, both in humans and animals, is based on using anthelmintic drugs, which has res...

Full description

Bibliographic Details
Main Authors: Luis Miguel Flores-Velázquez, María Teresa Ruiz-Campillo, Guillem Herrera-Torres, Álvaro Martínez-Moreno, Francisco Javier Martínez-Moreno, Rafael Zafra, Leandro Buffoni, Pablo José Rufino-Moya, Verónica Molina-Hernández, José Pérez
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2023.1270064/full
_version_ 1797397517729529856
author Luis Miguel Flores-Velázquez
María Teresa Ruiz-Campillo
Guillem Herrera-Torres
Álvaro Martínez-Moreno
Francisco Javier Martínez-Moreno
Rafael Zafra
Leandro Buffoni
Pablo José Rufino-Moya
Verónica Molina-Hernández
José Pérez
author_facet Luis Miguel Flores-Velázquez
María Teresa Ruiz-Campillo
Guillem Herrera-Torres
Álvaro Martínez-Moreno
Francisco Javier Martínez-Moreno
Rafael Zafra
Leandro Buffoni
Pablo José Rufino-Moya
Verónica Molina-Hernández
José Pérez
author_sort Luis Miguel Flores-Velázquez
collection DOAJ
description Fasciola hepatica is distributed worldwide, causing substantial economic losses in the animal husbandry industry. Human fasciolosis is an emerging zoonosis in Andean America, Asia, and Africa. The control of the disease, both in humans and animals, is based on using anthelmintic drugs, which has resulted in increased resistance to the most effective anthelmintics, such as triclabendazole, in many countries. This, together with the concerns about drug residues in food and the environment, has increased the interest in preventive measures such as a vaccine to help control the disease in endemic areas. Despite important efforts over the past two decades and the work carried out with numerous vaccine candidates, none of them has demonstrated consistent and reproducible protection in target species. This is at least in part due to the high immunomodulation capacity of the parasite, making ineffective the host response in susceptible species such as ruminants. It is widely accepted that a deeper knowledge of the host-parasite interactions is needed for a more rational design of vaccine candidates. In recent years, the use of emerging technologies has notably increased the amount of data about these interactions. In the present study, current knowledge of host-parasite interactions and their implication in Fasciola hepatica vaccine development is reviewed.
first_indexed 2024-03-09T01:11:10Z
format Article
id doaj.art-f44bad0e8a47425986e8e01a3dddcc74
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-03-09T01:11:10Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-f44bad0e8a47425986e8e01a3dddcc742023-12-11T06:35:06ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692023-12-011010.3389/fvets.2023.12700641270064Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine developmentLuis Miguel Flores-Velázquez0María Teresa Ruiz-Campillo1Guillem Herrera-Torres2Álvaro Martínez-Moreno3Francisco Javier Martínez-Moreno4Rafael Zafra5Leandro Buffoni6Pablo José Rufino-Moya7Verónica Molina-Hernández8José Pérez9Unidad de Anatomía, Histología y Patología Veterinaria, Escuela de Medicina Veterinaria, Facultad de Ciencias Naturales, Universidad San Sebastián, Campus Puerto Montt, Puerto Montt, ChileDepartamento de Anatomía y Anatomía Patológica Comparadas y Toxicología, UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, SpainDepartamento de Anatomía y Anatomía Patológica Comparadas y Toxicología, UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, SpainDepartamento de Sanidad Animal (Área de Parasitología), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, SpainDepartamento de Sanidad Animal (Área de Parasitología), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, SpainDepartamento de Sanidad Animal (Área de Parasitología), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, SpainDepartamento de Sanidad Animal (Área de Parasitología), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, SpainDepartamento de Sanidad Animal (Área de Parasitología), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, SpainDepartamento de Anatomía y Anatomía Patológica Comparadas y Toxicología, UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, SpainDepartamento de Anatomía y Anatomía Patológica Comparadas y Toxicología, UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, Córdoba, SpainFasciola hepatica is distributed worldwide, causing substantial economic losses in the animal husbandry industry. Human fasciolosis is an emerging zoonosis in Andean America, Asia, and Africa. The control of the disease, both in humans and animals, is based on using anthelmintic drugs, which has resulted in increased resistance to the most effective anthelmintics, such as triclabendazole, in many countries. This, together with the concerns about drug residues in food and the environment, has increased the interest in preventive measures such as a vaccine to help control the disease in endemic areas. Despite important efforts over the past two decades and the work carried out with numerous vaccine candidates, none of them has demonstrated consistent and reproducible protection in target species. This is at least in part due to the high immunomodulation capacity of the parasite, making ineffective the host response in susceptible species such as ruminants. It is widely accepted that a deeper knowledge of the host-parasite interactions is needed for a more rational design of vaccine candidates. In recent years, the use of emerging technologies has notably increased the amount of data about these interactions. In the present study, current knowledge of host-parasite interactions and their implication in Fasciola hepatica vaccine development is reviewed.https://www.frontiersin.org/articles/10.3389/fvets.2023.1270064/fullFasciola hepaticapathogenesishost-pathogen interactionimmunomodulationvaccinelivestock
spellingShingle Luis Miguel Flores-Velázquez
María Teresa Ruiz-Campillo
Guillem Herrera-Torres
Álvaro Martínez-Moreno
Francisco Javier Martínez-Moreno
Rafael Zafra
Leandro Buffoni
Pablo José Rufino-Moya
Verónica Molina-Hernández
José Pérez
Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development
Frontiers in Veterinary Science
Fasciola hepatica
pathogenesis
host-pathogen interaction
immunomodulation
vaccine
livestock
title Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development
title_full Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development
title_fullStr Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development
title_full_unstemmed Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development
title_short Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development
title_sort fasciolosis pathogenesis host parasite interactions and implication in vaccine development
topic Fasciola hepatica
pathogenesis
host-pathogen interaction
immunomodulation
vaccine
livestock
url https://www.frontiersin.org/articles/10.3389/fvets.2023.1270064/full
work_keys_str_mv AT luismiguelfloresvelazquez fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment
AT mariateresaruizcampillo fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment
AT guillemherreratorres fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment
AT alvaromartinezmoreno fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment
AT franciscojaviermartinezmoreno fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment
AT rafaelzafra fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment
AT leandrobuffoni fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment
AT pablojoserufinomoya fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment
AT veronicamolinahernandez fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment
AT joseperez fasciolosispathogenesishostparasiteinteractionsandimplicationinvaccinedevelopment